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The thermostabilized DOP construct Complexes with these agonists were subsequently used to determine the BRIL-DOP-KGCHM07 and BRIL-DOP-DPI-287 crystal structures at 2.8 Å and 3.3 Å resolution, respectively. Except for local ligand-specific variations, the two agonist-bound DOP 
